Surface Oncology, Inc. Common Stock
SURF
SURF was delisted on the 7th of September, 2023.
59 hedge funds and large institutions have $149M invested in Surface Oncology, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 10 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
150% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 10
34% more funds holding
Funds holding: 44 → 59 (+15)
2% more capital invested
Capital invested by funds: $145M → $149M (+$3.03M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.9M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$5.24M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.75M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.46M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$13.4M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.3M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$9.7M |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$3.13M |
| 5 |
Renaissance Technologies
New York
|
-$1.08M |
SURF Hedge Fund Activity: Q3 2020 in Review
59 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q3 2020, worth a combined $149M — up 2.1% from $145M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new SURF positions and 10 closed out — a net gain of 15 holders — while 22 added to existing stakes and 8 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $10.9M. The largest seller was BVF Inc, exiting entirely with an estimated $13.4M sold.
- 59 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q3 2020, up from 44 in Q2 2020.
- Funds reported $149M of Surface Oncology, Inc. Common Stock stock for Q3 2020, up 2.1% quarter-over-quarter.
- 25 funds opened new Surface Oncology, Inc. Common Stock positions in Q3 2020 and 10 closed out, a net change of +15 holders.
- The largest Surface Oncology, Inc. Common Stock buyer in Q3 2020 was Point72 Asset Management, an estimated $10.9M added.
- The largest Surface Oncology, Inc. Common Stock seller in Q3 2020 was BVF Inc, an estimated $13.4M sold.
Based on aggregated 13F filings for Q3 2020.